Case Reports

Anti-TIF-1γ-positive dermatomyositis associated with colorectal adenocarcinoma: a case report

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 23 September 2025
257
Views
141
Downloads

Authors

Dermatomyositis (DM) is a rare autoimmune disease characterized by inflammatory involvement of skin and muscles, often associated with malignancy, particularly in the presence of anti-transcription intermediary factor 1 gamma (TIF-1γ) antibodies. This case report describes a 57-year-old Senegalese man with anti-TIF-1γ-positive DM and colorectal adenocarcinoma with liver metastases, presenting with severe dermatological symptoms such as ulcerations, the “red on white” sign, and scalp pustulosis, as well as systemic features including dysphagia and muscle weakness. Diagnosis was confirmed through clinical evaluation, serological testing, and histopathology. Treatment with corticosteroids, intravenous immunoglobulin (IVIG), and surgical tumor resection led to significant improvement. This case underscores the importance of recognizing DM’s dermatological signs, conducting thorough malignancy screening, and implementing a multidisciplinary approach for effective management and improved outcomes, given the rarity of the association with colorectal cancer.

Downloads

Download data is not yet available.

Citations

1. Fiorentino DF, Kuo K, Chung L, et al. Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis. J Am Acad Dermatol 2015;72:449-55. DOI: https://doi.org/10.1016/j.jaad.2014.12.009
2. Hodgkinson LM, Wu TT, Fiorentino DF. Dermatomyositis autoantibodies: how can we maximize utility? Ann Transl Med 2021;9:433. DOI: https://doi.org/10.21037/atm-20-5175
3. Trallero-Araguás E, Rodrigo-Pendás JÁ, Selva-O’Callaghan A, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis. Arthritis Rheum 2012;64:523-32. DOI: https://doi.org/10.1002/art.33379
4. Fujimoto M, Hamaguchi Y, Kaji K, et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 2012;64:513-22. DOI: https://doi.org/10.1002/art.33403
5. Best M, Molinari N, Chasset F, et al. Use of anti-transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with cancer: A systematic review and meta-analysis. Acta Derm Venereol 2019;99:256-62. DOI: https://doi.org/10.2340/00015555-3091
6. Ono R, Kumagae T, Igasaki M, et al. Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature. J Med Case Rep 2021;15. DOI: https://doi.org/10.1186/s13256-021-02664-1
7. Callen JP. Dermatomyositis. Lancet 2000;355:53-7. DOI: https://doi.org/10.1016/S0140-6736(99)05157-0
8. Franciosi E, Houk L, Rashighi M. Characteristic vascular finding in TIF1-γ dermatomyositis. BMJ Case Rep 2021;14. DOI: https://doi.org/10.1136/bcr-2020-240174
9. Mugii N, Hasegawa M, Matsushita T, et al. Oropharyngeal dysphagia in dermatomyositis: Associations with clinical and laboratory features including autoantibodies. PLoS One 2016;11. DOI: https://doi.org/10.1371/journal.pone.0154746
10. Harada Y, Tominaga M, Iitoh E, et al. Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy. J Clin Med 2022;11. DOI: https://doi.org/10.3390/jcm11071925
11. Xiong A, Qiang Y, Cao Y, et al. The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: A systematic review and meta-analysis. Mod Rheumatol 2023;33:533-42. DOI: https://doi.org/10.1093/mr/roac057

How to Cite



1.
Spagnolini S, Kalaja A, Macchi S, Stanganelli I, De Felici Del Giudice MB. Anti-TIF-1γ-positive dermatomyositis associated with colorectal adenocarcinoma: a case report. Dermatol Reports [Internet]. 2025 Sep. 23 [cited 2026 Apr. 18];. Available from: https://journals.pagepress.net/dr/article/view/10489